International Journal of Clinical Case Reports 2024, Vol.14, No.4, 202-209 http://medscipublisher.com/index.php/ijccr 208 Emami N.C., Cavazos T.B., Rashkin S., Cario C.L., Graff R.E., Tai C., Mefford J., Kachuri L., Wan E., Wong S., Aaronson D., Presti J., Habel L., Shan J., Ranatunga D., Chao C., Ghai N.R., Jorgenson E., Sakoda L., and Witte J., 2020, A large-scale association study detects novel rare variants, risk genes, functional elements, and polygenic architecture of prostate cancer susceptibility, Cancer Research, 81: 1695-1703. https://doi.org/10.1158/0008-5472.CAN-20-2635 PMID: 33293427 PMCID: PMC8137514 Feng T., Wang J., Cheng K., Lu Q., Zhao R., Wang S., Zhang Q., Ge L., Pan J., Song G., and Wang L., 2021, IL13Rα1 prevents a castration-resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation, Cancer Biology & Medicine, 19: 1008-1028. https://doi.org/10.20892/j.issn.2095-3941.2020.0583 PMID: 34652890 PMCID: PMC9334759 Hankey W., Chen Z., and Wang Q., 2020, Shaping chromatin states in prostate cancer by pioneer transcription factors, Cancer Research, 80(11): 2427-2436. https://doi.org/10.1158/0008-5472.CAN-19-3447 PMID: 32094298 PMCID: PMC7299826 Heise M., Jarzemski P., Bąk A., Junkiert-Czarnecka A., Pilarska-Deltow M., and Haus O., 2019, G84E germline mutation in HOXB13 gene is associated with increased prostate cancer risk in polish men, Polish Journal of Pathology, 70(2): 127-133. https://doi.org/10.5114/pjp.2019.87103 PMID: 31556563 Johng D., Haffner M.C., Mooney S.M., Esopi D.M., Ewing C.M., Chen S., and Isaacs W.B., 2016, Global analyses of HOXB13-regulated transcription reveal a potential link between HOXB13 G84Eand prostate cancer risk, Cancer Research, 76: 2027-2027. https://doi.org/10.1158/1538-7445.AM2016-2027 Kim E.H., Cao D., Mahajan N., Andriole G., and Mahajan K., 2020, ACK1–AR and AR–HOXB13 signaling axes: epigenetic regulation of lethal prostate cancers, NAR Cancer, 2: zcaa018. https://doi.org/10.1093/narcan/zcaa018 PMID: 32885168 PMCID: PMC7454006 Kote-Jarai Z., Mikropoulos C., Leongamornlert D., Dadaev T., Tymrakiewicz M., Saunders E., Jones M., Jugurnauth-Little S., Govindasami K., and Guy M., 2015, Prevalence of the HOXB13 G84E germline mutation in british men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes, Annals of Oncology, 26(4): 756-761. https://doi.org/10.1093/annonc/mdv004 PMID: 25595936 Kurihara S., Matsui H., Ohtake N., Aoki M., Sekine Y., Arai S., Koike H., Suzuki K., and Miyazawa Y., 2022, Variants in HOXB13, G132E and F127C, are associated with prostate cancer risk in Japanese men, Cancer Diagnosis & Prognosis, 2(5): 542-548. https://doi.org/10.21873/cdp.10139 PMID: 36060024 PMCID: PMC9425588 Liu C., Armstrong C., Ning S., Yang J.C., Lou W., Lombard A., Zhao J., Wu C., Yu A., Evans C., Tepper C., Li P.K., and Gao A., 2021, ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signaling, Oncogene, 40: 5379-5392. https://doi.org/10.1038/s41388-021-01914-2 PMID: 34272475 PMCID: PMC8413131 Lotan T., Torres A.F.C., Zhang M., Tosoian J., Guedes L.B., Fedor H., Hicks J., Ewing C., Isaacs S., Johng D., De Marzo A.D., and Isaacs W., 2017, Somatic molecular subtyping of prostate tumors fromHOXB13 G84Ecarriers, Oncotarget, 8: 22772-22782. https://doi.org/10.18632/oncotarget.15196 Lu X., Fong K., Wang F., Gritsina G., Baca S., Berchuck J., Ross J., Corey E., Chandel N., Catalona W., Yang X.J., Freedman M., and Yu J., 2021, HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming, Nature Genetics, 54(5): 670-683. https://doi.org/10.1038/s41588-022-01045-8. PMID: 35468964 PMCID: PMC9117466 Maia S., Cardoso M., Pinto P., Pinheiro M., Santos C., Peixoto A., Bento M., Oliveira J., Henrique R., Jerónimo C., and Teixeira M., 2015, Identification of two novel HOXB13 germline mutations in portuguese prostate cancer patients, PLoS ONE, 10(7): e0132728. https://doi.org/10.1371/journal.pone.0132728 PMID: 26176944 PMCID: PMC4503425 Misawa A., Kondo Y., Takei H., and Takizawa T., 2021, Long noncoding RNA HOXA11-AS and transcription factor HOXB13 modulate the expression of bone metastasis-related genes in prostate cancer, Genes, 12(2): 182. https://doi.org/10.3390/genes12020182 Nerlakanti N., Yao J., Nguyen D., Patel A.K., Eroshkin A., Lawrence H., Ayaz M., Kuenzi B., Agarwal N., Chen Y., Gunawan S., Karim R., Berndt N., Puskás J., Magliocco A., Coppola D., Dhillon J., Zhang J., Shymalagovindarajan S., Rix U., Kim Y., Perera R., Lawrence N., Schonbrunn E., and Mahajan K., 2018, Targeting the BRD4-HOXB13 coregulated transcriptional networks with bromodomain-kinase inhibitors to suppress metastatic castration-resistant prostate cancer, Molecular Cancer Therapeutics, 17(12): 2796-2810. https://doi.org/10.1158/1535-7163.MCT-18-0602 PMID: 30242092 PMCID: PMC6528782
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==